Your browser doesn't support javascript.
loading
Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population.
Sunthankar, Sudeep D; Kannankeril, Prince J; Gaedigk, Andrea; Radbill, Andrew E; Fish, Frank A; Van Driest, Sara L.
Afiliação
  • Sunthankar SD; Thomas P. Graham Jr. Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center|, Nashville, Tennessee, USA.
  • Kannankeril PJ; Center for Pediatric Precision Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Gaedigk A; Thomas P. Graham Jr. Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center|, Nashville, Tennessee, USA.
  • Radbill AE; Center for Pediatric Precision Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Fish FA; Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Van Driest SL; Thomas P. Graham Jr. Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center|, Nashville, Tennessee, USA.
Clin Transl Sci ; 15(7): 1787-1795, 2022 07.
Article em En | MEDLINE | ID: mdl-35514162
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propafenona / Síndrome do QT Longo / Citocromo P-450 CYP2D6 / Antiarrítmicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propafenona / Síndrome do QT Longo / Citocromo P-450 CYP2D6 / Antiarrítmicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article